Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FMTX

Forma Therapeutics (FMTX) Stock Price, News & Analysis

Forma Therapeutics logo

About Forma Therapeutics Stock (NASDAQ:FMTX)

Advanced Chart

Key Stats

Today's Range
$20.01
$20.01
50-Day Range
$19.91
$20.01
52-Week Range
$4.95
$20.68
Volume
1 shs
Average Volume
847,595 shs
Market Capitalization
$957.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forma Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FMTX Stock News Headlines

Forma Therapeutics Holdings, Inc. (FMTX)
What Steve Bannon revealed about Trump’s gold play
A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your IRA could be at risk. Here’s how to prepare.tc pixel
4 Analysts Have This to Say About Forma Therapeutics Hldgs
Forma Therapeutics: Rare Disease Play
Novo Nordisk To Acquire Forma Therapeutics - Quick Facts
See More Headlines

FMTX Stock Analysis - Frequently Asked Questions

Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) announced its quarterly earnings data on Friday, November, 12th. The company reported ($0.91) earnings per share for the quarter, beating analysts' consensus estimates of ($0.96) by $0.05.

Forma Therapeutics (FMTX) raised $201 million in an IPO on Friday, June 19th 2020. The company issued 11,800,000 shares at $16.00-$18.00 per share. Jefferies' SVB Leerink and Credit Suisse acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Forma Therapeutics investors own include Tesla (TSLA), HubSpot (HUBS), Cheniere Energy (LNG), Netflix (NFLX), Marvell Technology (MRVL) and Viper Energy (VNOM).

Company Calendar

Last Earnings
11/12/2021
Today
8/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:FMTX
CIK
1538927
Fax
N/A
Employees
166
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.00)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$172.96 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-39.68%
Return on Assets
-35.33%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.74
Quick Ratio
12.74

Sales & Book Value

Annual Sales
$100.56 million
Price / Sales
9.52
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.51 per share
Price / Book
1.90

Miscellaneous

Outstanding Shares
47,853,000
Free Float
45,082,000
Market Cap
$957.54 million
Optionable
Not Optionable
Beta
-0.94

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:FMTX) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners